Ebos Group
EBOS Group is a diversified Australasian marketer, wholesaler, and distributor of healthcare, medical, and pharmaceutical products. The company operates across both the healthcare and animal care sectors, providing a broad range of products and services to meet the needs of its diverse customer base.
Short position
Ebos Group (ASX:EBO) has 0.41% of its shares on issue reported as short positions as of 5 Oct 2026, or about 862,476 shares. Over the past 30 days that figure has fallen 0.23 percentage points, and over 90 days it has fallen 0.39 percentage points. Its highest recorded short interest was 0.83% in August 2026. EBO is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4Ebos Group (EBO) financials
Results, ratios and statements
Latest result
Year to 30 Jun 2026 (FY26) vs FY25, figures in AUD, the reporting currency
- Revenue
- $13.49BM (source: ASX (Markit))vs $12.27BM (source: ASX (Markit)) (FY25)
- ASX (Markit), as at 29 Sep 2026
- NPAT
- $225.2MM (source: ASX (Markit))vs $215.1MM (source: ASX (Markit)) (FY25)
- ASX (Markit), as at 29 Sep 2026
- EPS (basic)
- n/avs n/a (FY25)
- Rev YoY
- +9.9%FY
- EPS YoY
- n/aFY
- ASX (Markit)
Key ratios
Year to 30 Jun 2026 (FY); no balance sheet aligned with this period; prices to 9 Oct 2026
- Gross margin
- n/a
- Operating margin
- n/a
- Net margin
- 1.7%
- FCF margin
- n/a
- ROE
- n/a
- ROA
- n/a
- FCF conversion
- n/a
- Net debt (excl. leases)
- n/a
- Net debt / EBITDA
- n/a
- Current ratio
- n/a
- Interest cover
- n/a
- Cash dividends paid / net profit
- n/a
- Market cap
- n/a (no share count we can vouch for)
- P/E
- n/a
- P/B
- n/a (no share count we can vouch for)
Ratios use the reporting currency (AUD); market cap is in AUD. Sources: Yahoo Finance and ASX (Markit), as at 29 Sep 2026.
Financial statements
Figures in AUD, the reporting currency; Yahoo Finance unless marked
| Line item | FY26 | FY25 | FY24 | FY23 |
|---|---|---|---|---|
| Revenue | $13.49BM (source: ASX (Markit)) | $12.27BM (source: ASX (Markit)) | $13.19BM (source: ASX (Markit)) | $12.24BM (source: ASX (Markit)) |
| NPAT | $225.2MM (source: ASX (Markit)) | $215.1MM (source: ASX (Markit)) | $271.5MM (source: ASX (Markit)) | $253.4MM (source: ASX (Markit)) |
| Shares | 206.9M | 203.2M | 193.2M | 191.6M |
- ASX (Markit)
Financial reports
The company's own filings, newest first
- Full Year Results Media ReleaseFull Year Results19 Aug 2026via asx_announcements
- ASX Appendix 4EAnnual Results19 Aug 2026via asx_announcements
- Annual ReportAnnual Report19 Aug 2026via asx_announcements
- Advance Notice - Full Year ResultsFull Year Results11 Aug 2026via asx_announcements
- ASX Appendix 4DHalf Year Results25 Feb 2026via asx_announcements
- Interim ReportHalf Year Results25 Feb 2026via asx_announcements
- Advance Notice - Half Year ResultsHalf Year Results22 Jan 2026via asx_announcements
- Click hereFinancial Report31 Dec 2025via crawler
- ASX Appendix 4EAnnual Results27 Aug 2025via asx_announcements
- 2025 Annual ReportAnnual Report27 Aug 2025via asx_announcements
Showing 10 of 23 reports